81 FR 61684 - Board of Scientific Counselors, Office of Infectious Diseases (BSC, OID)

DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention

Federal Register Volume 81, Issue 173 (September 7, 2016)

Page Range61684-61685
FR Document2016-21400

Federal Register, Volume 81 Issue 173 (Wednesday, September 7, 2016)
[Federal Register Volume 81, Number 173 (Wednesday, September 7, 2016)]
[Notices]
[Pages 61684-61685]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2016-21400]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Board of Scientific Counselors, Office of Infectious Diseases 
(BSC, OID)

    In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC), announces the following meeting of the aforementioned 
committee:
    Times and Dates: 8:30 a.m.-5:00 p.m., EDT, September 27, 2016; 8:00 
a.m.-12:00 p.m., EDT, September 28, 2016.
    Place: CDC, Global Communications Center, 1600 Clifton Road NE., 
Building 19, Auditorium B3, Atlanta, Georgia 30333.
    Status: The meeting is open to the public, limited only by the 
space available.
    Purpose: The BSC, OID, provides advice and guidance to the 
Secretary, Department of Health and Human Services; the Director, CDC; 
the Director, OID; and the Directors of the National Center for 
Immunization and Respiratory Diseases, the National Center for Emerging 
and Zoonotic Infectious Diseases, and the National Center for HIV/AIDS, 
Viral Hepatitis, STD, and TB Prevention, CDC, in the following areas: 
strategies, goals, and priorities for programs; research within the 
national centers; and overall strategic direction and focus of OID and 
the national centers.
    Matters for Discussion: The meeting will include updates from CDC's 
infectious disease national centers; a report from the Board's Food 
Safety Modernization Act Surveillance Working Group; and focused 
discussions on several program priorities, including viral hepatitis, 
Zika, and antimicrobial resistance.
    Agenda items are subject to change as priorities dictate.
    Contact Person for More Information: Robin Moseley, M.A.T., 
Designated Federal Officer, OID, CDC, 1600 Clifton Road NE., Mailstop 
D10, Atlanta, Georgia 30333, Telephone: (404) 639-4461.
    The Director, Management Analysis and Services Office has been 
delegated the authority to sign Federal Register notices pertaining to 
announcements of meetings and other committee management activities, 
for both the Centers for Disease Control and Prevention and the Agency 
for Toxic Substances and Disease Registry.

[[Page 61685]]


Elaine L. Baker, MPH, DLP,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention (CDC).
[FR Doc. 2016-21400 Filed 9-6-16; 8:45 am]
 BILLING CODE 4163-18-P


Current View
CategoryRegulatory Information
CollectionFederal Register
sudoc ClassAE 2.7:
GS 4.107:
AE 2.106:
PublisherOffice of the Federal Register, National Archives and Records Administration
SectionNotices
Dates8:30 a.m.-5:00 p.m., EDT, September 27, 2016; 8:00 a.m.-12:00 p.m., EDT, September 28, 2016.
FR Citation81 FR 61684 

2024 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR